IL324359A - תרופות המכילות כלאטורים עם תכונה של החזקת יוני אבץ חזקה לטיפול בתסמינים ומחלות הנגרמות על ידי מיקרואורגניזמים/מחלות הנגרמות על ידי רעלים או נוירוטוקסינים/סרטן/מספר תסמונות - Google Patents
תרופות המכילות כלאטורים עם תכונה של החזקת יוני אבץ חזקה לטיפול בתסמינים ומחלות הנגרמות על ידי מיקרואורגניזמים/מחלות הנגרמות על ידי רעלים או נוירוטוקסינים/סרטן/מספר תסמונותInfo
- Publication number
- IL324359A IL324359A IL324359A IL32435925A IL324359A IL 324359 A IL324359 A IL 324359A IL 324359 A IL324359 A IL 324359A IL 32435925 A IL32435925 A IL 32435925A IL 324359 A IL324359 A IL 324359A
- Authority
- IL
- Israel
- Prior art keywords
- acid
- pharmaceuticals
- symptoms
- tissues
- ions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/132—Amines having two or more amino groups, e.g. spermidine, putrescine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/04—Chelating agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Surgery (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Toxicology (AREA)
- Diabetes (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| VN1202302967 | 2023-05-05 | ||
| PCT/IB2024/054083 WO2024231774A1 (en) | 2023-05-05 | 2024-04-26 | Pharmaceuticals containing chelators with strong zn ions-holding feature for the treatment of symptoms and diseases caused by microorganisms/diseases caused by toxins or neurotoxins/cancer/several syndromes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL324359A true IL324359A (he) | 2025-12-01 |
Family
ID=91129511
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL324359A IL324359A (he) | 2023-05-05 | 2025-10-30 | תרופות המכילות כלאטורים עם תכונה של החזקת יוני אבץ חזקה לטיפול בתסמינים ומחלות הנגרמות על ידי מיקרואורגניזמים/מחלות הנגרמות על ידי רעלים או נוירוטוקסינים/סרטן/מספר תסמונות |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP4704820A1 (he) |
| CN (1) | CN121419766A (he) |
| AU (1) | AU2024269697A1 (he) |
| IL (1) | IL324359A (he) |
| MX (1) | MX2025013222A (he) |
| WO (1) | WO2024231774A1 (he) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5494935A (en) * | 1992-01-17 | 1996-02-27 | University Of Utah Research Foundation | Methods for oral decorporation of metals |
| US20040033260A1 (en) * | 1999-10-19 | 2004-02-19 | The Procter & Gamble Company | Compositions for prevention and treatment of cold and influenza-like symptoms comprising chelated zinc |
| US7582418B2 (en) | 2004-11-03 | 2009-09-01 | Albion Laboratories, Inc. | Antimicrobial chelates |
| KR20100084501A (ko) | 2007-07-27 | 2010-07-26 | 아톤 파마, 인코포레이티드 | 금속 오염 대응책으로서의 트리엔틴 및 페니실라민의 용도 |
| WO2017049529A1 (en) | 2015-09-24 | 2017-03-30 | Innolife Co., Ltd. | A pharmaceutical composition comprising a copper chelating tetramine and the use thereof |
| CN107325891A (zh) * | 2017-06-16 | 2017-11-07 | 中原工学院 | 一种特效去除重金属的全天然绿色果蔬洗涤盐 |
| US20220280450A1 (en) * | 2021-03-05 | 2022-09-08 | Philera New Zealand Ltd. | Prevention and treatment of coronavirus and related respiratory infections |
-
2024
- 2024-04-26 CN CN202480030622.0A patent/CN121419766A/zh active Pending
- 2024-04-26 WO PCT/IB2024/054083 patent/WO2024231774A1/en not_active Ceased
- 2024-04-26 AU AU2024269697A patent/AU2024269697A1/en active Pending
- 2024-04-26 EP EP24726729.7A patent/EP4704820A1/en active Pending
-
2025
- 2025-10-30 IL IL324359A patent/IL324359A/he unknown
- 2025-11-04 MX MX2025013222A patent/MX2025013222A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX2025013222A (es) | 2025-12-01 |
| AU2024269697A1 (en) | 2025-12-04 |
| CN121419766A (zh) | 2026-01-27 |
| WO2024231774A1 (en) | 2024-11-14 |
| EP4704820A1 (en) | 2026-03-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2791485T3 (es) | Método y material para complejación en el sitio activo de moléculas biológicas | |
| US10195239B2 (en) | Extract of Trigonella foenum-graecum | |
| CN109316536A (zh) | 一种皮肤黏膜消毒剂及其制备方法 | |
| AU3715397A (en) | Antimicrobial treatment for herpes simplex virus and other infectious diseases | |
| TW200830991A (en) | TTO-based disinfectants & anesthetics for use in aquaculture | |
| EP4203920A1 (en) | Liposomal ozone nanosolutions | |
| RU2144828C1 (ru) | Способ лечения водных животных и композиция, содержащая каепутовое масло | |
| JPWO2011092835A1 (ja) | 持続性口腔用殺菌消毒液 | |
| WO2005012503A1 (ja) | 新規乳酸菌並びに生体賦活型乳酸菌製剤及び生体に対する感染症の予防剤と治療剤 | |
| WO2024231774A1 (en) | Pharmaceuticals containing chelators with strong zn ions-holding feature for the treatment of symptoms and diseases caused by microorganisms/diseases caused by toxins or neurotoxins/cancer/several syndromes | |
| KR101934828B1 (ko) | 해수와, 본래 해수와 섞이지 않는 적어도 하나의 화합물을 함유하는 수용성 이온 용액 | |
| CN102088984A (zh) | 幽门螺杆菌驱除剂和驱除方法 | |
| Thormar | Antibacterial effects of lipids: historical review (1881 to 1960) | |
| CN113368007B (zh) | 一种口腔用多功能气雾剂及其制备工艺 | |
| US20230240989A1 (en) | Liposomal ozone nanosolutions | |
| CN108208034A (zh) | 一种杀虫和肥效一体的生物杀虫剂及其制备方法 | |
| CN101480428A (zh) | 橄叶乐果精华液及其用途 | |
| US10206899B2 (en) | Method for removing bacterial biofilms | |
| RU2477149C1 (ru) | Биоцидный состав для пропитки салфеток | |
| CN110946995A (zh) | 天然草本宠物专用除臭除虫消毒剂 | |
| KR20100117261A (ko) | 샴푸 조성물 | |
| CA3085312C (en) | Antibacterial compositions comprising an alkyleth sulfate salt; a zinc salt; and alkyl sulfoacetate and/or alkyl sulfosuccinate surfactants | |
| CN104056293B (zh) | 一种空气清新剂 | |
| US20120135085A1 (en) | Method and composition for disinfection and purification | |
| US20050276832A1 (en) | Topical compositions and uses thereof for treating aquatic animals subjected to disinfection and vaccination |